SCHEDULE 13G

CUSIP No.

28657F103

Names of Reporting Persons

Actyus Private Equity SGIIC, S.A.

Check the appropriate box if a member of a Group (see instructions)

(a)

(b)

Sec Use Only

Citizenship or Place of Organization

SPAIN

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 587,818.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 517,818.00
8	Shared Dispositive Power 0.00

Aggregate Amount Beneficially Owned by Each Reporting Person

587,818.00

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in row (9)

5.45 %

Type of Reporting Person (See Instructions)

SCHEDULE 13G

Item 1.

(a)

Name of issuer:

Elicio Therapeutics, Inc.

(b)

Address of issuer's principal executive offices:

The Company's principal executive office is located at 451 D Street, 5th Floor, Boston, Massachusetts, 02210.

Item 2.

(a)

Name of person filing:

This statement is filed by Actyus Private Equity SGIIC, S.A., a Sociedad Anonima organized under the laws of Spain ("Actyus" or the "Reporting Person"), with respect to the shares of Common Stock (as defined in Item 2(d) below) held by Azahar Private Capital, SCR, S.A., a Sociedad Anonima organized under the laws of Spain ("Azahar"). Actyus is the sole management company of Azahar and acts on behalf of Azahar investors' interests.

(b)

Address or principal business office or, if none, residence:

The address of the business office of the Reporting Person is Calle Serrano 37, Madrid, 28001, Spain.

(c)

Citizenship:

Spain

(d)

Title of class of securities:

Common Stock, par value $0.01 per share

(e)

CUSIP No.:

28657F103

Item 3.

If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

(a)

Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);

(b)

Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);

(c)

Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);

(d)

Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);

(e)

An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

(f)

An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

(g)

A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

(h)

A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i)

A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j)

A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:

(k)

Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).

Item 4.

Ownership

(a)

Amount beneficially owned:

The percentage set forth in this Schedule 13G is calculated based upon an aggregate of 10,791,236 shares of Common Stock outstanding as of November 8, 2024, as reported in the Company's Registration Statement on Form 10Q filed with the Securities and Exchange Commission on November 13, 2024.

(b)

Percent of class:

5.45%

(c)

Number of shares as to which the person has:

(i) Sole power to vote or to direct the vote:

587,818

(ii) Shared power to vote or to direct the vote:

(iii) Sole power to dispose or to direct the disposition of:

587,818

(iv) Shared power to dispose or to direct the disposition of:

Item 5.

Ownership of 5 Percent or Less of a Class.

Item 6.

Ownership of more than 5 Percent on Behalf of Another Person.

If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.

See Item 2.

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

Not Applicable

Item 8.

Identification and Classification of Members of the Group.

Not Applicable

Item 9.

Notice of Dissolution of Group.

Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Actyus Private Equity SGIIC, S.A.

Signature:	/s/ Jasmina Armengol
Name/Title:	Jasmina Armengol / Director of Finance and Operations
Date:	01/07/2025

Signature:	/s/ Alessia Carretie Columbo
Name/Title:	Alessia Carrestie Columbo / Director of Business Development
Date:	01/07/2025